CYTK Equities

Companies
Cytokinetics Kicks Off Phase 1 Study of Aficamten in Japanese Cohort Jun 17, 2024
Companies
Cytokinetics to Present Multiple Studies at the 34th International ALS/MND Symposium Nov 30, 2023